XML 98 R82.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information - Schedule of Consolidated Statements of Operations (Details) - Other Operating Segment [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development salaries and related expenses, other than stock-based compensation $ 4,493 $ 7,406
General and administrative salaries and related expenses, other than stock-based compensations 2,707 3,101
Clinical trials 12,720 12,301
Research and development stock based compensation 711 600
General and administrative stock based compensation 1,380 1,248
Research and development depreciation expenses 2,306 1,486
General and administrative depreciation expenses 616 317
Goodwill, IPR&D and Other long-lived asset impairment 13,495 8,084
Other segment items [1] 3,038 9,980
Total Operating expenses $ 41,466 $ 44,523
[1] Other segment items include gain from early lease termination and all remaining costs necessary to operate our business, which primarily include external professional services, rent, insurance and other administrative expenses, and are presented net of grants received.